Peter Eickholz Selected Research

Aggressive Periodontitis (Periodontosis)

11/2018	Oral health-related quality of life and standard of treatment in aggressive periodontitis patients more than 5 years after therapy.
10/2017	A haplotype block downstream of plasminogen is associated with chronic and aggressive periodontitis.
2/2015	Genetic evidence for PLASMINOGEN as a shared genetic risk factor of coronary artery disease and periodontitis.
7/2014	Periodontal pathogens and associated factors in aggressive periodontitis: results 5-17 years after active periodontal therapy.
6/2014	SLC23A1 polymorphism rs6596473 in the vitamin C transporter SVCT1 is associated with aggressive periodontitis.
9/2013	Caries experience after periodontal treatment in aggressive and chronic periodontitis: results of a 10-year follow-up.
8/2012	Increased systemic elastase and C-reactive protein in aggressive periodontitis (CLOI-D-00160R2).
1/2012	IL-1-polymorphism and severity of periodontal disease.
7/2011	Tooth loss in aggressive periodontitis after active periodontal therapy: patient-related and tooth-related prognostic factors.
4/2011	Patient-related risk factors for tooth loss in aggressive periodontitis after active periodontal therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Eickholz Research Topics

Disease

34	Periodontitis 06/2022 - 03/2004
18	Hemorrhage 01/2022 - 04/2005
14	Aggressive Periodontitis (Periodontosis) 11/2018 - 07/2007
12	Tooth Loss 01/2022 - 02/2008
10	Chronic Periodontitis 12/2018 - 01/2007
5	Furcation Defects 01/2022 - 10/2002
4	Periodontal Pocket (Periodontal Pockets) 05/2017 - 11/2002
3	Gingival Recession 01/2021 - 01/2018
3	Inflammation (Inflammations) 01/2020 - 02/2002
3	Suppuration 10/2019 - 08/2016
3	Infections 11/2017 - 08/2013
3	Periodontal Diseases (Periodontal Disease) 12/2015 - 01/2012
3	Gingival Overgrowth 11/2011 - 09/2006
2	Vasculitis (Vasculitides) 01/2022 - 10/2018
2	Peri-Implantitis 05/2017 - 01/2015
1	Vascular System Injuries 01/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Glomerulonephritis 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Overweight 01/2020
1	Gingivitis 01/2019
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2018
1	Atherosclerosis 10/2017
1	Mucositis 05/2017
1	Reinfection 01/2017
1	Diabetes Mellitus 01/2016
1	Calculi (Calculus) 04/2015
1	Disease Progression 04/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2014
1	Tooth Mobility 01/2014
1	Coronary Disease (Coronary Heart Disease) 08/2012
1	Tinea Capitis 11/2011
1	Hemophilia A (Haemophilia) 10/2010
1	von Willebrand Diseases (von Willebrand's Disease) 10/2010

Drug/Important Bio-Agent (IBA)

15	Tuberculin (PPD)IBA 01/2022 - 10/2002
13	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 11/2002
7	APTIBA 01/2022 - 02/2008
6	Interleukin-1 (Interleukin 1)IBA 12/2020 - 02/2008
5	Doxycycline (Periostat)FDA LinkGeneric 05/2012 - 02/2002
4	Cathepsin CIBA 01/2022 - 04/2008
4	Amoxicillin (Wymox)FDA LinkGeneric 01/2020 - 09/2015
4	Metronidazole (Metric)FDA LinkGeneric 01/2020 - 09/2015
3	C-Reactive ProteinIBA 06/2022 - 08/2012
3	AntigensIBA 10/2018 - 08/2014
2	Indicators and Reagents (Reagents)IBA 01/2022 - 07/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2018
2	NucleotidesIBA 01/2018 - 01/2017
2	Factor VIII (Coagulation Factor VIII)IBA 01/2018 - 08/2014
2	PlasminogenIBA 10/2017 - 02/2015
2	alpha-DefensinsIBA 01/2017 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 06/2015 - 06/2014
2	Pancreatic Elastase (Elastase)IBA 04/2013 - 08/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2011 - 09/2006
2	Pharmaceutical PreparationsIBA 02/2010 - 11/2002
1	Leukocyte Elastase (Neutrophil Elastase)IBA 06/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	PlacebosIBA 01/2020
1	Ribosomal DNA (rDNA)IBA 01/2020
1	Orosomucoid (Seromucoid)IBA 01/2020
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2020
1	SmokeIBA 01/2020
1	AdipokinesIBA 01/2020
1	Myeloblastin (Proteinase 3)IBA 10/2018
1	16S Ribosomal RNAIBA 05/2017
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2017
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	Vesicle-Associated Membrane Protein 3IBA 02/2015
1	Biological ProductsIBA 01/2015
1	Interferon-betaIBA 12/2014
1	Antimicrobial PeptidesIBA 09/2014
1	EnzymesIBA 09/2014
1	Peptides (Polypeptides)IBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 09/2014
1	von Willebrand FactorIBA 08/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2014
1	IGF-I-IGFBP-3 complex FDA Link 06/2013
1	leukotoxinIBA 12/2012
1	InterleukinsIBA 01/2012
1	BM 42304 (MCHP)IBA 01/2012
1	Citric Acid (Citrate)FDA LinkGeneric 11/2009
1	poly(lactide) (polylactic acid)IBA 11/2009
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2008

Therapy/Procedure

39	Therapeutics 06/2022 - 02/2004
5	Oral Hygiene (Dental Hygiene) 01/2020 - 02/2008
3	Debridement 01/2020 - 05/2012
3	Root Planing 01/2020 - 12/2005
2	Crown Lengthening 01/2018 - 01/2018
2	Aftercare (After-Treatment) 08/2013 - 11/2011
2	Guided Tissue Regeneration 01/2006 - 03/2004
1	Precision Medicine 01/2022
1	Surgical Amputation (Amputations) 01/2020
1	Eye Protective Devices (Goggles) 11/2017
1	Personal Protective Equipment 11/2017
1	Oral Medicine 11/2017
1	Secondary Prevention 05/2012
1	Tooth Extraction (Tooth Extractions) 10/2010